Taichi Isobe

Higashi, 8128582, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Real-World Comparative Study of Atezolizumab-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer.

Real-World Comparative Study of Atezolizumab-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer.

Journal: Cancers

Published: October 08, 2025

Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).

Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 27, 2025

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Journal: Japanese journal of clinical oncology

Published: August 14, 2025

Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer.

Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer.

Journal: Molecular therapy. Methods & clinical development

Published: February 16, 2025

Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.

Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.

Journal: International cancer conference journal

Published: February 12, 2025

The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11).

The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11).

Journal: bioRxiv : the preprint server for biology

Published: February 03, 2025

Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis.

Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 20, 2024

Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.

Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.

Journal: Internal medicine (Tokyo, Japan)

Published: October 20, 2024

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study.

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study.

Journal: Japanese journal of clinical oncology

Published: June 20, 2024

Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.

Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.

Journal: JCO precision oncology

Published: May 15, 2024

Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

Journal: Nature communications

Published: December 13, 2023

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Journal: BMC cancer

Published: August 05, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026